Comparing Two Group Therapy Treatments for Binge Eating Disorder
NCT ID: NCT00071578
Last Updated: 2013-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2003-10-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Binge Eating Disorder
NCT00041743
Effectiveness of Binge Eating Disorder Treatments
NCT00060762
Guided Self-Help for Binge Eating Disorder
NCT01282736
The Psychological Treatment of Overweight Binge Eaters Minority Supplement
NCT01208259
Binge Eating Disorder Treatment Study
NCT00848367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in this study will complete assessment interviews regarding their eating disorder and associated problems. Similar assessments will be conducted at the end of the study. Participants will then be randomly assigned to one of two therapy groups. Participants in one group will focus on the role of self-esteem, self-awareness, and personal effectiveness in binge eating. Participants in the other group will focus on the role of negative emotions and binge eating. Both treatments will involve a 30 to 40 minute pre-treatment individual orientation session, followed by 20 weeks of weekly group therapy. Sessions will take place over 22 weeks, or approximately 6 months (18 weekly sessions followed by 2 biweekly sessions). Follow-up assessments will take place at 3 months, 6 months, and 12 months after study completion to assess maintenance of treatment effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Group therapy Negative Emotion Focus
Group Psychotherapy-Negative Emotion Focus
20 weekly sessions, 2 hours, group format
2
Group Psychotherapy- Self Esteem Focus
Group Psychotherapy- Self-Esteem Focus
20 weekly sessions, 2 hours, group format
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group Psychotherapy-Negative Emotion Focus
20 weekly sessions, 2 hours, group format
Group Psychotherapy- Self-Esteem Focus
20 weekly sessions, 2 hours, group format
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reside in the San Francisco Bay Area
* Willing to commit to the study requirements
Exclusion Criteria
* History of bipolar illness or schizophrenia
* Receiving treatment for an eating disorder (or unwillingness to discontinue treatment upon study entry)
* Membership in weight-loss groups such as Weight Watchers or Jenny Craig (or unwillingness to discontinue membership upon study entry)
* Use of medications affecting weight or appetite. Antidepressants are acceptable, but doses of any psychiatric medication must have been stable for at least 3 months prior to study start
* Breast-feeding
* Require gastric-bypass surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Debra L. Safer
Asst professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Debra L Safer, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University Dept of Psychiatry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University Medical Center
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.